<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>33 Locally-Advanced Gastric | GI Surgical Oncology</title>
  <meta name="description" content="Orientation Manual for GI Surgical Oncology Service" />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="33 Locally-Advanced Gastric | GI Surgical Oncology" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://github.com/gisurgonc/orientation" />
  
  <meta property="og:description" content="Orientation Manual for GI Surgical Oncology Service" />
  

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="33 Locally-Advanced Gastric | GI Surgical Oncology" />
  
  <meta name="twitter:description" content="Orientation Manual for GI Surgical Oncology Service" />
  




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  <link rel="apple-touch-icon-precomposed" sizes="120x120" href="images/icon120.png" />
  <link rel="shortcut icon" href="images/favicon.io" type="image/x-icon" />
<link rel="prev" href="gast_superficial.html"/>
<link rel="next" href="hereditary-diffuse-gastric-cancer.html"/>
<script src="libs/header-attrs-2.11/header-attrs.js"></script>
<script src="libs/jquery-3.5.1/jquery-3.5.1.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>



<style type="text/css">
/* Used with Pandoc 2.11+ new --citeproc when CSL is used */
div.csl-bib-body { }
div.csl-entry {
  clear: both;
}
.hanging div.csl-entry {
  margin-left:2em;
  text-indent:-2em;
}
div.csl-left-margin {
  min-width:2em;
  float:left;
}
div.csl-right-inline {
  margin-left:2em;
  padding-left:1em;
}
div.csl-indent {
  margin-left: 2em;
}
</style>

<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li>GI Surgical Oncology</li>

<li class="divider"></li>
<li><a href="index.html#Intro" id="toc-Intro"><span class="toc-section-number">1</span> Overview</a>
<ul>
<li><a href="index.html#absences" id="toc-absences"><span class="toc-section-number">1.1</span> Absences</a></li>
<li><a href="index.html#communication" id="toc-communication"><span class="toc-section-number">1.2</span> Communication</a></li>
<li><a href="index.html#inpatients" id="toc-inpatients"><span class="toc-section-number">1.3</span> Inpatients</a></li>
<li><a href="index.html#er-admits" id="toc-er-admits"><span class="toc-section-number">1.4</span> ER admits</a></li>
<li><a href="index.html#medical-records" id="toc-medical-records"><span class="toc-section-number">1.5</span> Medical Records</a></li>
<li><a href="index.html#operative-logs" id="toc-operative-logs"><span class="toc-section-number">1.6</span> Operative Logs</a></li>
<li><a href="index.html#case-assignment" id="toc-case-assignment"><span class="toc-section-number">1.7</span> Case Assignment</a></li>
<li><a href="index.html#clinic" id="toc-clinic"><span class="toc-section-number">1.8</span> Clinic</a></li>
<li><a href="index.html#work-hours" id="toc-work-hours"><span class="toc-section-number">1.9</span> Work Hours</a></li>
</ul></li>
<li><a href="cmc-inpatient.html#cmc-inpatient" id="toc-cmc-inpatient"><span class="toc-section-number">2</span> CMC Inpatient</a>
<ul>
<li><a href="cmc-inpatient.html#admissions" id="toc-admissions"><span class="toc-section-number">2.1</span> Admissions</a></li>
<li><a href="cmc-inpatient.html#rounds" id="toc-rounds"><span class="toc-section-number">2.2</span> Rounds</a></li>
<li><a href="cmc-inpatient.html#resident-epic-teams" id="toc-resident-epic-teams"><span class="toc-section-number">2.3</span> Resident Epic teams:</a></li>
<li><a href="cmc-inpatient.html#attending-epic-teams" id="toc-attending-epic-teams"><span class="toc-section-number">2.4</span> Attending Epic teams:</a></li>
<li><a href="cmc-inpatient.html#consults" id="toc-consults"><span class="toc-section-number">2.5</span> Consults</a></li>
<li><a href="cmc-inpatient.html#postop-clinic-appts" id="toc-postop-clinic-appts"><span class="toc-section-number">2.6</span> Postop Clinic Appts</a></li>
<li><a href="cmc-inpatient.html#conferences" id="toc-conferences"><span class="toc-section-number">2.7</span> Conferences</a></li>
</ul></li>
<li><a href="pineville-inpatient.html#pineville-inpatient" id="toc-pineville-inpatient"><span class="toc-section-number">3</span> Pineville Inpatient</a>
<ul>
<li><a href="pineville-inpatient.html#rounds-1" id="toc-rounds-1"><span class="toc-section-number">3.1</span> Rounds</a></li>
<li><a href="pineville-inpatient.html#resident-halo-teams" id="toc-resident-halo-teams"><span class="toc-section-number">3.2</span> Resident Halo teams:</a></li>
<li><a href="pineville-inpatient.html#attending-halo-teams" id="toc-attending-halo-teams"><span class="toc-section-number">3.3</span> Attending Halo teams:</a></li>
<li><a href="pineville-inpatient.html#consults-1" id="toc-consults-1"><span class="toc-section-number">3.4</span> Consults</a></li>
<li><a href="pineville-inpatient.html#postop-clinic-appts-1" id="toc-postop-clinic-appts-1"><span class="toc-section-number">3.5</span> Postop Clinic Appts</a></li>
<li><a href="pineville-inpatient.html#conferences-1" id="toc-conferences-1"><span class="toc-section-number">3.6</span> Conferences</a></li>
</ul></li>
<li><a href="rounds-2.html#rounds-2" id="toc-rounds-2"><span class="toc-section-number">4</span> Rounds</a></li>
<li><a href="progress-notes.html#progress-notes" id="toc-progress-notes"><span class="toc-section-number">5</span> Progress Notes</a></li>
<li><a href="discharges.html#discharges" id="toc-discharges"><span class="toc-section-number">6</span> Discharges</a></li>
<li><a href="education.html#education" id="toc-education"><span class="toc-section-number">7</span> Education</a>
<ul>
<li><a href="education.html#student-emr-notes-policy" id="toc-student-emr-notes-policy"><span class="toc-section-number">7.0.1</span> Student EMR Notes Policy</a></li>
</ul></li>
<li><a href="clinic-1.html#clinic-1" id="toc-clinic-1"><span class="toc-section-number">8</span> Clinic</a>
<ul>
<li><a href="clinic-1.html#salo-clinic" id="toc-salo-clinic"><span class="toc-section-number">8.1</span> Salo Clinic</a></li>
</ul></li>
<li><a href="mie_postop.html#mie_postop" id="toc-mie_postop"><span class="toc-section-number">9</span> Postop Care after Esophagectomy</a>
<ul>
<li><a href="mie_postop.html#weaning-tube-feeds-in-diabetics" id="toc-weaning-tube-feeds-in-diabetics"><span class="toc-section-number">9.1</span> Weaning Tube Feeds in Diabetics</a></li>
</ul></li>
<li><a href="#part-postoperative-care" id="toc-part-postoperative-care">(PART*) Postoperative Care</a></li>
<li><a href="colectomy.html#colectomy" id="toc-colectomy"><span class="toc-section-number">10</span> Colectomy</a></li>
<li><a href="lar-ileostomy.html#lar-ileostomy" id="toc-lar-ileostomy"><span class="toc-section-number">11</span> LAR + Ileostomy</a></li>
<li><a href="abdominoperineal-resection.html#abdominoperineal-resection" id="toc-abdominoperineal-resection"><span class="toc-section-number">12</span> Abdominoperineal Resection</a></li>
<li><a href="esophagectomy-postop.html#esophagectomy-postop" id="toc-esophagectomy-postop"><span class="toc-section-number">13</span> Esophagectomy Postop</a></li>
<li><a href="esophagectomy-ward.html#esophagectomy-ward" id="toc-esophagectomy-ward"><span class="toc-section-number">14</span> Esophagectomy Ward</a>
<ul>
<li><a href="esophagectomy-ward.html#anti-hypertensives" id="toc-anti-hypertensives"><span class="toc-section-number">14.1</span> Anti-Hypertensives</a></li>
<li><a href="esophagectomy-ward.html#chest-tubes" id="toc-chest-tubes"><span class="toc-section-number">14.2</span> Chest tubes</a></li>
<li><a href="esophagectomy-ward.html#gi-medicines" id="toc-gi-medicines"><span class="toc-section-number">14.3</span> GI Medicines</a></li>
<li><a href="esophagectomy-ward.html#leak_evaluation" id="toc-leak_evaluation"><span class="toc-section-number">14.4</span> Evaluation for leak</a>
<ul>
<li><a href="esophagectomy-ward.html#drain_amylase" id="toc-drain_amylase"><span class="toc-section-number">14.4.1</span> Drain Amylase</a></li>
<li><a href="esophagectomy-ward.html#ct_esophagram" id="toc-ct_esophagram"><span class="toc-section-number">14.4.2</span> CT esophagram</a></li>
</ul></li>
<li><a href="esophagectomy-ward.html#anastomotic-leak-treatment" id="toc-anastomotic-leak-treatment"><span class="toc-section-number">14.5</span> Anastomotic Leak Treatment</a></li>
</ul></li>
<li><a href="jejunostomy-feedings.html#jejunostomy-feedings" id="toc-jejunostomy-feedings"><span class="toc-section-number">15</span> Jejunostomy Feedings</a>
<ul>
<li><a href="jejunostomy-feedings.html#med-administration-via-j-tubes" id="toc-med-administration-via-j-tubes"><span class="toc-section-number">15.1</span> Med Administration via J-Tubes</a></li>
<li><a href="jejunostomy-feedings.html#occluded-jejunostomy-tubes" id="toc-occluded-jejunostomy-tubes"><span class="toc-section-number">15.2</span> Occluded Jejunostomy Tubes</a></li>
<li><a href="jejunostomy-feedings.html#jejunostomy_diabetes" id="toc-jejunostomy_diabetes"><span class="toc-section-number">15.3</span> Jejunostomy + Diabetes</a></li>
</ul></li>
<li><a href="#part-hill-or" id="toc-part-hill-or">(PART*) Hill OR</a></li>
<li><a href="colorectal-cases---hill.html#colorectal-cases---hill" id="toc-colorectal-cases---hill"><span class="toc-section-number">16</span> Colorectal Cases - Hill</a></li>
<li><a href="#part-salo-or" id="toc-part-salo-or">(PART*) Salo OR</a></li>
<li><a href="cv_port_salo.html#cv_port_salo" id="toc-cv_port_salo"><span class="toc-section-number">17</span> Central Venous Port (IJ)</a></li>
<li><a href="lap-jejunostomy.html#lap-jejunostomy" id="toc-lap-jejunostomy"><span class="toc-section-number">18</span> Lap Jejunostomy</a></li>
<li><a href="lap_gastrostomy_salo.html#lap_gastrostomy_salo" id="toc-lap_gastrostomy_salo"><span class="toc-section-number">19</span> Lap Gastrostomy</a></li>
<li><a href="esophagectomy-1-stage.html#esophagectomy-1-stage" id="toc-esophagectomy-1-stage"><span class="toc-section-number">20</span> Esophagectomy 1 Stage</a>
<ul>
<li><a href="esophagectomy-1-stage.html#indications" id="toc-indications"><span class="toc-section-number">20.1</span> Indications</a></li>
<li><a href="esophagectomy-1-stage.html#room-prep" id="toc-room-prep"><span class="toc-section-number">20.2</span> Room Prep</a>
<ul>
<li><a href="esophagectomy-1-stage.html#time-out" id="toc-time-out"><span class="toc-section-number">20.2.1</span> Time Out</a></li>
</ul></li>
<li><a href="esophagectomy-1-stage.html#gastric-mobilization" id="toc-gastric-mobilization"><span class="toc-section-number">20.3</span> Gastric Mobilization</a>
<ul>
<li><a href="esophagectomy-1-stage.html#distal-mobilization" id="toc-distal-mobilization"><span class="toc-section-number">20.3.1</span> Distal mobilization</a></li>
<li><a href="esophagectomy-1-stage.html#left-gastric-artery" id="toc-left-gastric-artery"><span class="toc-section-number">20.3.2</span> Left gastric artery</a></li>
<li><a href="esophagectomy-1-stage.html#mediastinal-dissection" id="toc-mediastinal-dissection"><span class="toc-section-number">20.3.3</span> Mediastinal dissection</a></li>
<li><a href="esophagectomy-1-stage.html#division-of-esophagus-four-phase" id="toc-division-of-esophagus-four-phase"><span class="toc-section-number">20.3.4</span> Division of Esophagus (Four-Phase)</a></li>
<li><a href="esophagectomy-1-stage.html#entry-into-right-chest" id="toc-entry-into-right-chest"><span class="toc-section-number">20.3.5</span> Entry into right chest</a></li>
</ul></li>
</ul></li>
<li><a href="#part-esophageal-cancer" id="toc-part-esophageal-cancer">(PART*) Esophageal Cancer</a></li>
<li><a href="EsoIntro.html#EsoIntro" id="toc-EsoIntro"><span class="toc-section-number">21</span> Esophageal Overview</a></li>
<li><a href="staging.html#staging" id="toc-staging"><span class="toc-section-number">22</span> Staging</a></li>
<li><a href="superficial.html#superficial" id="toc-superficial"><span class="toc-section-number">23</span> Superficial EsoCa</a>
<ul>
<li><a href="superficial.html#emr" id="toc-emr"><span class="toc-section-number">23.1</span> Endscopic Mucosal Resection (EMR)</a></li>
</ul></li>
<li><a href="localized.html#localized" id="toc-localized"><span class="toc-section-number">24</span> Localized EsoCa</a>
<ul>
<li><a href="localized.html#t1b-tumors" id="toc-t1b-tumors"><span class="toc-section-number">24.1</span> T1b Tumors</a></li>
<li><a href="localized.html#t2n0-tumors" id="toc-t2n0-tumors"><span class="toc-section-number">24.2</span> T2N0 Tumors</a></li>
<li><a href="localized.html#staging-of-t2n0-tumors" id="toc-staging-of-t2n0-tumors"><span class="toc-section-number">24.3</span> Staging of T2N0 Tumors</a></li>
</ul></li>
<li><a href="locally_advanced.html#locally_advanced" id="toc-locally_advanced"><span class="toc-section-number">25</span> Locally Advanced EsoCa</a>
<ul>
<li><a href="locally_advanced.html#trimodality" id="toc-trimodality"><span class="toc-section-number">25.1</span> Trimodality Therapy</a>
<ul>
<li><a href="locally_advanced.html#neoadjuvant-chemort-for-scca" id="toc-neoadjuvant-chemort-for-scca"><span class="toc-section-number">25.1.1</span> Neoadjuvant chemoRT for SCCA</a></li>
<li><a href="locally_advanced.html#neoadjuvant-chemotheraphy-followed-by-surgery" id="toc-neoadjuvant-chemotheraphy-followed-by-surgery"><span class="toc-section-number">25.1.2</span> Neoadjuvant chemotheraphy followed by surgery</a></li>
</ul></li>
<li><a href="locally_advanced.html#ge-junction" id="toc-ge-junction"><span class="toc-section-number">25.2</span> GE Junction</a></li>
<li><a href="locally_advanced.html#induction-chemotherapy-followed-by-chemort" id="toc-induction-chemotherapy-followed-by-chemort"><span class="toc-section-number">25.3</span> Induction chemotherapy followed by chemoRT</a></li>
<li><a href="locally_advanced.html#postoperative-chemoradiation" id="toc-postoperative-chemoradiation"><span class="toc-section-number">25.4</span> Postoperative chemoradiation</a></li>
</ul></li>
<li><a href="eso_dcrt.html#eso_dcrt" id="toc-eso_dcrt"><span class="toc-section-number">26</span> Chemoradiation</a>
<ul>
<li><a href="eso_dcrt.html#phase-ii-studies" id="toc-phase-ii-studies"><span class="toc-section-number">26.1</span> Phase II Studies</a></li>
<li><a href="eso_dcrt.html#chemort-vs-trimodality-therapy" id="toc-chemort-vs-trimodality-therapy"><span class="toc-section-number">26.2</span> ChemoRT vs Trimodality therapy</a></li>
</ul></li>
<li><a href="radiation.html#radiation" id="toc-radiation"><span class="toc-section-number">27</span> Radiation</a></li>
<li><a href="esophagectomy.html#esophagectomy" id="toc-esophagectomy"><span class="toc-section-number">28</span> Esophagectomy</a>
<ul>
<li><a href="esophagectomy.html#preoperative-evaluation" id="toc-preoperative-evaluation"><span class="toc-section-number">28.0.1</span> Preoperative Evaluation</a></li>
<li><a href="esophagectomy.html#minimally-invasive-esophagectomy" id="toc-minimally-invasive-esophagectomy"><span class="toc-section-number">28.1</span> Minimally-invasive Esophagectomy</a></li>
<li><a href="esophagectomy.html#transthoracic" id="toc-transthoracic"><span class="toc-section-number">28.2</span> Transthoracic</a></li>
<li><a href="esophagectomy.html#transhiatal" id="toc-transhiatal"><span class="toc-section-number">28.3</span> Transhiatal</a></li>
<li><a href="esophagectomy.html#three-hole" id="toc-three-hole"><span class="toc-section-number">28.4</span> Three-hole</a></li>
<li><a href="esophagectomy.html#extended-lymphadenectomy" id="toc-extended-lymphadenectomy"><span class="toc-section-number">28.5</span> Extended lymphadenectomy</a></li>
<li><a href="esophagectomy.html#early-recovery-pathways" id="toc-early-recovery-pathways"><span class="toc-section-number">28.6</span> Early Recovery Pathways</a></li>
<li><a href="esophagectomy.html#salvage-esophagectomy" id="toc-salvage-esophagectomy"><span class="toc-section-number">28.7</span> Salvage esophagectomy</a></li>
</ul></li>
<li><a href="eso_metastatic.html#eso_metastatic" id="toc-eso_metastatic"><span class="toc-section-number">29</span> Metastatic EsoCa</a>
<ul>
<li><a href="eso_metastatic.html#palliative-radiation" id="toc-palliative-radiation"><span class="toc-section-number">29.1</span> Palliative radiation</a></li>
<li><a href="eso_metastatic.html#chemoradiation-vs-chemotherapy-in-stage-iv" id="toc-chemoradiation-vs-chemotherapy-in-stage-iv"><span class="toc-section-number">29.2</span> Chemoradiation vs chemotherapy in Stage IV</a></li>
<li><a href="eso_metastatic.html#stents-for-malignant-disease" id="toc-stents-for-malignant-disease"><span class="toc-section-number">29.3</span> Stents for malignant disease</a></li>
</ul></li>
<li><a href="eso_survivorship.html#eso_survivorship" id="toc-eso_survivorship"><span class="toc-section-number">30</span> Survivorship</a>
<ul>
<li><a href="eso_survivorship.html#nutritional-consequences-of-esophagectomy" id="toc-nutritional-consequences-of-esophagectomy"><span class="toc-section-number">30.1</span> Nutritional consequences of esophagectomy</a>
<ul>
<li><a href="eso_survivorship.html#vitamin-d-deficiency" id="toc-vitamin-d-deficiency"><span class="toc-section-number">30.1.1</span> Vitamin D deficiency</a></li>
</ul></li>
<li><a href="eso_survivorship.html#cardiac-toxicity-of-radiation" id="toc-cardiac-toxicity-of-radiation"><span class="toc-section-number">30.2</span> Cardiac toxicity of radiation</a></li>
<li><a href="eso_survivorship.html#eso_surveillance" id="toc-eso_surveillance"><span class="toc-section-number">30.3</span> Surveillance</a></li>
</ul></li>
<li><a href="#part-gastric-cancer" id="toc-part-gastric-cancer">(PART*) Gastric Cancer</a></li>
<li><a href="gastric-overview.html#gastric-overview" id="toc-gastric-overview"><span class="toc-section-number">31</span> Gastric Overview</a></li>
<li><a href="gast_superficial.html#gast_superficial" id="toc-gast_superficial"><span class="toc-section-number">32</span> Superficial Gastric</a></li>
<li><a href="locally-advanced-gastric.html#locally-advanced-gastric" id="toc-locally-advanced-gastric"><span class="toc-section-number">33</span> Locally-Advanced Gastric</a>
<ul>
<li><a href="locally-advanced-gastric.html#preoperative-chemotherapy" id="toc-preoperative-chemotherapy"><span class="toc-section-number">33.1</span> Preoperative Chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemotherapy" id="toc-postoperative-chemotherapy"><span class="toc-section-number">33.2</span> Postoperative chemotherapy</a></li>
<li><a href="locally-advanced-gastric.html#postoperative-chemoradiation-1" id="toc-postoperative-chemoradiation-1"><span class="toc-section-number">33.3</span> Postoperative chemoradiation</a></li>
<li><a href="locally-advanced-gastric.html#preoperative-chemoradiation" id="toc-preoperative-chemoradiation"><span class="toc-section-number">33.4</span> Preoperative chemoradiation</a></li>
</ul></li>
<li><a href="hereditary-diffuse-gastric-cancer.html#hereditary-diffuse-gastric-cancer" id="toc-hereditary-diffuse-gastric-cancer"><span class="toc-section-number">34</span> Hereditary Diffuse Gastric Cancer</a></li>
<li><a href="#part-colon-cancer" id="toc-part-colon-cancer">(PART*) Colon Cancer</a></li>
<li><a href="colorectal-overview.html#colorectal-overview" id="toc-colorectal-overview"><span class="toc-section-number">35</span> Colorectal Overview</a></li>
<li><a href="colon-cancer-staging.html#colon-cancer-staging" id="toc-colon-cancer-staging"><span class="toc-section-number">36</span> Colon Cancer Staging</a>
<ul>
<li><a href="colon-cancer-staging.html#cea-level" id="toc-cea-level"><span class="toc-section-number">36.1</span> CEA level</a></li>
<li><a href="colon-cancer-staging.html#ct-scan" id="toc-ct-scan"><span class="toc-section-number">36.2</span> CT Scan</a></li>
<li><a href="colon-cancer-staging.html#pet-scan" id="toc-pet-scan"><span class="toc-section-number">36.3</span> PET scan</a>
<ul>
<li><a href="colon-cancer-staging.html#indications-for-pet-in-colorectal-cancer" id="toc-indications-for-pet-in-colorectal-cancer"><span class="toc-section-number">36.3.1</span> Indications for PET in colorectal cancer:</a></li>
</ul></li>
<li><a href="colon-cancer-staging.html#adjuvant-therapy" id="toc-adjuvant-therapy"><span class="toc-section-number">36.4</span> Adjuvant Therapy</a></li>
</ul></li>
<li><a href="stage-iv-colon-cancer.html#stage-iv-colon-cancer" id="toc-stage-iv-colon-cancer"><span class="toc-section-number">37</span> Stage IV Colon Cancer</a>
<ul>
<li><a href="stage-iv-colon-cancer.html#carcinomatosis" id="toc-carcinomatosis"><span class="toc-section-number">37.1</span> Carcinomatosis</a></li>
<li><a href="stage-iv-colon-cancer.html#colon-resection-in-stage-iv-colon-cancer" id="toc-colon-resection-in-stage-iv-colon-cancer"><span class="toc-section-number">37.2</span> Colon resection in stage IV colon cancer</a></li>
<li><a href="stage-iv-colon-cancer.html#immunotherapy-for-dmmr-msi-high" id="toc-immunotherapy-for-dmmr-msi-high"><span class="toc-section-number">37.3</span> Immunotherapy for dMMR (MSI high)</a></li>
</ul></li>
<li><a href="colectomy-1.html#colectomy-1" id="toc-colectomy-1"><span class="toc-section-number">38</span> Colectomy</a>
<ul>
<li><a href="colectomy-1.html#extended-node-dissection" id="toc-extended-node-dissection"><span class="toc-section-number">38.1</span> Extended Node dissection</a></li>
</ul></li>
<li><a href="chemotherapy.html#chemotherapy" id="toc-chemotherapy"><span class="toc-section-number">39</span> Chemotherapy</a>
<ul>
<li><a href="chemotherapy.html#neoadjuvant-chemotherapy" id="toc-neoadjuvant-chemotherapy"><span class="toc-section-number">39.1</span> Neoadjuvant Chemotherapy</a></li>
</ul></li>
<li><a href="#part-rectal-cancer" id="toc-part-rectal-cancer">(PART*) Rectal Cancer</a></li>
<li><a href="rectal-overview.html#rectal-overview" id="toc-rectal-overview"><span class="toc-section-number">40</span> Rectal Overview</a></li>
<li><a href="rectal-cancer-staging.html#rectal-cancer-staging" id="toc-rectal-cancer-staging"><span class="toc-section-number">41</span> Rectal Cancer Staging</a>
<ul>
<li><a href="rectal-cancer-staging.html#mri-staging" id="toc-mri-staging"><span class="toc-section-number">41.1</span> MRI staging</a></li>
</ul></li>
<li><a href="rectal-cancer-surgery.html#rectal-cancer-surgery" id="toc-rectal-cancer-surgery"><span class="toc-section-number">42</span> Rectal Cancer Surgery</a></li>
<li><a href="rectal-adjuvant-therapy.html#rectal-adjuvant-therapy" id="toc-rectal-adjuvant-therapy"><span class="toc-section-number">43</span> Rectal Adjuvant Therapy</a>
<ul>
<li><a href="rectal-adjuvant-therapy.html#short-course-preoperative-therapy" id="toc-short-course-preoperative-therapy"><span class="toc-section-number">43.0.1</span> Short-course preoperative therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#total-neoadjuvant-therapy" id="toc-total-neoadjuvant-therapy"><span class="toc-section-number">43.0.2</span> Total Neoadjuvant therapy</a></li>
<li><a href="rectal-adjuvant-therapy.html#neoadjuvant-immunotherapy-msi-high" id="toc-neoadjuvant-immunotherapy-msi-high"><span class="toc-section-number">43.1</span> Neoadjuvant immunotherapy (MSI high)</a></li>
<li><a href="rectal-adjuvant-therapy.html#non-operative-management-of-rectal-cancer" id="toc-non-operative-management-of-rectal-cancer"><span class="toc-section-number">43.2</span> Non-operative management of Rectal Cancer</a></li>
</ul></li>
<li><a href="#part-sarcoma" id="toc-part-sarcoma">(PART*) Sarcoma</a></li>
<li><a href="soft-tissue-sarcomas.html#soft-tissue-sarcomas" id="toc-soft-tissue-sarcomas"><span class="toc-section-number">44</span> Soft Tissue Sarcomas</a>
<ul>
<li><a href="soft-tissue-sarcomas.html#desmoid-tumors" id="toc-desmoid-tumors"><span class="toc-section-number">44.1</span> Desmoid Tumors</a></li>
<li><a href="soft-tissue-sarcomas.html#retroperitoneal" id="toc-retroperitoneal"><span class="toc-section-number">44.2</span> Retroperitoneal</a></li>
<li><a href="soft-tissue-sarcomas.html#peritoneal-mesothelioma" id="toc-peritoneal-mesothelioma"><span class="toc-section-number">44.3</span> Peritoneal mesothelioma</a></li>
</ul></li>
<li><a href="references.html#references" id="toc-references">References</a></li>
<li class="divider"></li>
<li><a href="mailto:jonathan.salo@atriumhealth.org">Feedback and Updates</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">GI Surgical Oncology</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="locally-advanced-gastric" class="section level1" number="33">
<h1><span class="header-section-number">33</span> Locally-Advanced Gastric</h1>
<p>Locally-advanced gastric cancer (T3 or N<sup>+</sup>) is generally treated with some form of adjuvant therapy, which has been shown to improve upon the outcomes with surgery alone.</p>
<div id="preoperative-chemotherapy" class="section level2" number="33.1">
<h2><span class="header-section-number">33.1</span> Preoperative Chemotherapy</h2>
<p>FLOT chemotherapy <span class="citation">(<a href="#ref-al-batran1948" role="doc-biblioref">Al-Batran et al. 2019</a>)</span></p>
<p>MAGIC study randomized 503 patients to perioperative ‘sandwich’ therapy consisting of epirubicin, cisplatin, and 5-FU versus surgery alone. In the perioperative chemotherapy group, 4 cycles were administered prior to surgery, and 4 cycles afterwards. Tumors of the esophagus or gastroesophageal junction comprised 26% of the study population. While over 90% of patients assigned to the chemotherapy arm completed their preoperative chemotherapy, only 66% completed their postoperative therapy. Survival at 5 years was 36% in the perioperative chemotherapy group, compared with 24% in the surgery group (p&lt;0.001).<span class="citation">(<a href="#ref-cunningham11" role="doc-biblioref">Cunningham et al. 2006</a>)</span></p>
<p>CLASSIC clinical trial randomized 1033 patients with stage II or III gastric cancer after D2 gastrectomy to 6 months of adjuvant chemotherapy versus surgery alone. Three-year survival was improved in the chemotherapy group (74% <em>v</em> 59%).<span class="citation">(<a href="#ref-bang315" role="doc-biblioref">Bang et al. 2012</a>)</span></p>
<p>The FFCD trial randomized patients to preoperative chemotherapy with 2 or 3 yccles of cisplatin and 5-FU versus surgery alone. Tumors of the lower esophagus or gastroesophageal junction comprised 75% of the study population. Survival at 5 years was longer in the chemotherapy group (38%) versus 24% in the surgery alone group (p=0.02).<span class="citation">(<a href="#ref-ychou1715" role="doc-biblioref">Ychou et al. 2011</a>)</span></p>
</div>
<div id="postoperative-chemotherapy" class="section level2" number="33.2">
<h2><span class="header-section-number">33.2</span> Postoperative chemotherapy</h2>
<p>CLAASIC trial <span class="citation">(<a href="#ref-noh1389" role="doc-biblioref">Noh et al. 2014</a>)</span> <span class="citation">(<a href="#ref-bang315" role="doc-biblioref">Bang et al. 2012</a>)</span> patients with II or IIIB gastric cancer received gastrectomy with D2 node dissection randomized to postoperative chemotherapy with capecitabine and oxaliplatin. Chemotherapy group had improved 3-year DFS (74% vs 59% P&lt;.0001)</p>
</div>
<div id="postoperative-chemoradiation-1" class="section level2" number="33.3">
<h2><span class="header-section-number">33.3</span> Postoperative chemoradiation</h2>
<p>Intergroup 0116 trial <span class="citation">(<a href="#ref-macdonald725" role="doc-biblioref">Macdonald et al. 2001</a>)</span>
Surgical quality control was poor, as 90% were treated a limited lymph node dissection. Long-term followup, however <span class="citation">(<a href="#ref-smalley2327" role="doc-biblioref">Smalley et al. 2012</a>)</span> showed a persistent benefit of postoperative chemoradiation.</p>
<p>ARTIST trial 450 patients treated with a D1 <span class="math inline">\(\alpha\)</span> gastrectomy were randomized to adjuvant capcitibine and cisplatin versus chemoradiation consisting of two cycles of capcitabine/oxalipaltin followed by chemoradiation followed by chemotherapy. Overall 3- year survival did differ between groups (78.2% vs 74.2% p =0.86). A post-hoc analysis of patients with positive nodes showed a beneficial effect of chemoradiation (77.5% <em>v</em> 72.3% p=0.365).<span class="citation">(<a href="#ref-lee268" role="doc-biblioref">Lee et al. 2012</a>)</span></p>
<p>CRITICS trial treated all patients with preoperative chemoterhapy followed by surgery. Postoperative patients were then randomized between additional chemotherapy versus chemoradiation.</p>
</div>
<div id="preoperative-chemoradiation" class="section level2" number="33.4">
<h2><span class="header-section-number">33.4</span> Preoperative chemoradiation</h2>
<p><span class="citation">(<a href="#ref-ajani3953" role="doc-biblioref">Ajani et al. 2006</a>)</span></p>

</div>
</div>
<h3>References</h3>
<div id="refs" class="references csl-bib-body hanging-indent">
<div id="ref-ajani3953" class="csl-entry">
Ajani, Jaffer A., Kathryn Winter, Gordon S. Okawara, John H. Donohue, Peter W. T. Pisters, Christopher H. Crane, John F. Greskovich, et al. 2006. <span>“Phase <span>II</span> Trial of Preoperative Chemoradiation in Patients with Localized Gastric Adenocarcinoma (<span>RTOG</span> 9904): Quality of Combined Modality Therapy and Pathologic Response.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 24 (24): 3953–58. <a href="https://doi.org/10.1200/JCO.2006.06.4840">https://doi.org/10.1200/JCO.2006.06.4840</a>.
</div>
<div id="ref-al-batran1948" class="csl-entry">
Al-Batran, Salah-Eddin, Nils Homann, Claudia Pauligk, Thorsten O. Goetze, Johannes Meiler, Stefan Kasper, Hans-Georg Kopp, et al. 2019. <span>“Perioperative Chemotherapy with Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel Versus Fluorouracil or Capecitabine Plus Cisplatin and Epirubicin for Locally Advanced, Resectable Gastric or Gastro-Oesophageal Junction Adenocarcinoma (<span>Flot4</span>): A Randomised, Phase 2/3 Trial.”</span> <em>Lancet (London, England)</em> 393 (10184): 1948–57. <a href="https://doi.org/10.1016/S0140-6736(18)32557-1">https://doi.org/10.1016/S0140-6736(18)32557-1</a>.
</div>
<div id="ref-bang315" class="csl-entry">
Bang, Yung-Jue, Young-Woo Kim, Han-Kwang Yang, Hyun Cheol Chung, Young-Kyu Park, Kyung Hee Lee, Keun-Wook Lee, et al. 2012. <span>“Adjuvant Capecitabine and Oxaliplatin for Gastric Cancer After <span>D2</span> Gastrectomy (<span>CLASSIC</span>): A Phase 3 Open-Label, Randomised Controlled Trial.”</span> <em>Lancet (London, England)</em> 379 (9813): 315–21. <a href="https://doi.org/10.1016/S0140-6736(11)61873-4">https://doi.org/10.1016/S0140-6736(11)61873-4</a>.
</div>
<div id="ref-cunningham11" class="csl-entry">
Cunningham, David, William H. Allum, Sally P. Stenning, Jeremy N. Thompson, Cornelis J. H. Van de Velde, Marianne Nicolson, J. Howard Scarffe, et al. 2006. <span>“Perioperative Chemotherapy Versus Surgery Alone for Resectable Gastroesophageal Cancer.”</span> <em>The New England Journal of Medicine</em> 355 (1): 11–20. <a href="https://doi.org/10.1056/NEJMoa055531">https://doi.org/10.1056/NEJMoa055531</a>.
</div>
<div id="ref-lee268" class="csl-entry">
Lee, Jeeyun, Do Hoon Lim, Sung Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, et al. 2012. <span>“Phase <span>III</span> Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin with Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer with <span>D2</span> Lymph Node Dissection: The <span>ARTIST</span> Trial.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 30 (3): 268–73. <a href="https://doi.org/10.1200/JCO.2011.39.1953">https://doi.org/10.1200/JCO.2011.39.1953</a>.
</div>
<div id="ref-macdonald725" class="csl-entry">
Macdonald, J. S., S. R. Smalley, J. Benedetti, S. A. Hundahl, N. C. Estes, G. N. Stemmermann, D. G. Haller, et al. 2001. <span>“Chemoradiotherapy After Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction.”</span> <em>The New England Journal of Medicine</em> 345 (10): 725–30. <a href="https://doi.org/10.1056/NEJMoa010187">https://doi.org/10.1056/NEJMoa010187</a>.
</div>
<div id="ref-noh1389" class="csl-entry">
Noh, Sung Hoon, Sook Ryun Park, Han-Kwang Yang, Hyun Cheol Chung, Ik-Joo Chung, Sang-Woon Kim, Hyung-Ho Kim, et al. 2014. <span>“Adjuvant Capecitabine Plus Oxaliplatin for Gastric Cancer After <span>D2</span> Gastrectomy (<span>CLASSIC</span>): 5-Year Follow-up of an Open-Label, Randomised Phase 3 Trial.”</span> <em>The Lancet. Oncology</em> 15 (12): 1389–96. <a href="https://doi.org/10.1016/S1470-2045(14)70473-5">https://doi.org/10.1016/S1470-2045(14)70473-5</a>.
</div>
<div id="ref-smalley2327" class="csl-entry">
Smalley, Stephen R., Jacqueline K. Benedetti, Daniel G. Haller, Scott A. Hundahl, Norman C. Estes, Jaffer A. Ajani, Leonard L. Gunderson, et al. 2012. <span>“Updated Analysis of <span class="nocase">SWOG-directed</span> Intergroup Study 0116: A Phase <span>III</span> Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 30 (19): 2327–33. <a href="https://doi.org/10.1200/JCO.2011.36.7136">https://doi.org/10.1200/JCO.2011.36.7136</a>.
</div>
<div id="ref-ychou1715" class="csl-entry">
Ychou, Marc, Valérie Boige, Jean-Pierre Pignon, Thierry Conroy, Olivier Bouché, Gilles Lebreton, Muriel Ducourtieux, et al. 2011. <span>“Perioperative Chemotherapy Compared with Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An <span>FNCLCC</span> and <span>FFCD</span> Multicenter Phase <span>III</span> Trial.”</span> <em>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</em> 29 (13): 1715–21. <a href="https://doi.org/10.1200/JCO.2010.33.0597">https://doi.org/10.1200/JCO.2010.33.0597</a>.
</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="gast_superficial.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="hereditary-diffuse-gastric-cancer.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/jcsalo/gi_surgonc/edit/main/62-gastric_T3.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["gi_surgonc.pdf", "gi_surgonc.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "section",
"scroll_highlight": true,
"search": true,
"sharing": false
}
});
});
</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    var src = "true";
    if (src === "" || src === "true") src = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-MML-AM_CHTML";
    if (location.protocol !== "file:")
      if (/^https?:/.test(src))
        src = src.replace(/^https?:/, '');
    script.src = src;
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>
</body>

</html>
